# American Trial Using Tranexamic Acid in Thrombocytopenia

> **NCT02578901** · PHASE3 · COMPLETED · sponsor: **University of Washington** · enrollment: 330 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02578901
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2020-03
- **Final completion:** 2020-06-11
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578901, "American Trial Using Tranexamic Acid in Thrombocytopenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02578901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*